Skip to main content

Facilitators of, and barriers to, prostate cancer screening uptake: A descriptive phenomenological study of adult men in Namibia

Abstract

Background

Prostate cancer poses a significant health risk for aging men, with a higher prevalence observed in individuals aged 40 and above. The objectives of this study were to describe the facilitators of, and barriers to, prostate cancer screening among men between the ages of 50 and 70.

Methods

The study employed a qualitative descriptive phenomenological design. Data were collected at the oncology and urology departments of an intermediate hospital in Oshana region, Namibia using a semi-structured interview guide. Individual, face-to-face interviews were held between September and October 2022, after which the data gathered were analyzed thematically following Colaizzi’s 7-step method.

Results

Fifteen (15) participants took part in this study. The two major themes that were generated were: (1) Value of early detection, which described the participants’ perceptions regarding the facilitators of prostate cancer screening; and (2) Potential threats to PCa screening, which described the participants’ perceptions regarding the barriers to taking up cancer screening.

Conclusions

The study revealed modifiable barriers to PCa screening, including fear of stigmatization, lack of knowledge, and insufficient screening access, as well as facilitators that can be strengthened for successful prostate cancer screening, such as advanced age, history of prostate cancer, and social support. These findings emphasize the need to implement gender-specific campaigns that address masculinity, lack of knowledge, and cultural stigmatization.

Peer Review reports

Background

Prostate cancer (PCa) is a major cause of morbidity and mortality worldwide [1, 2], which primarily affects men above the age of 40 years. This malignant tumor originates in the prostate, a walnut sized gland located beneath the bladder that surrounds the upper part of the urethra [3]. Prostate cancer is more likely to develop in older and black men, with about six in 10 men being diagnosed with prostate cancer in their lifetimes [4]. Despite the evidence suggesting the risk of prostate cancer (PCa) starts at 40, it is more common from the age of 50 [5], yet there is limited research on the facilitators of, and barriers to, PCa screening in older patients.

PCa is ranked the second most frequently reported malignancy and the fifth leading cause of death globally [6, 7]. As with any cancer left untreated, prostate cancer follows a natural course, starting as tiny group of cancer cells that can grow into a full-blown tumor. Various studies have warned that prostate cancer is usually slow and progressive in nature, and presents with no symptoms until it reaches an advanced stage [8]. The incidence and mortality statistics vary significantly based on the geographic location of the affected population [6, 8]. The incidence rates of black men are also notably higher at 158.3 per 100,000 [9], compared to 63 per 100,000 for their male counterparts in Europe [8]. Sub-Saharan Africa has recorded some of the highest rates of years of life lost globally to PCa [10], with the mortality rate among men of African descent being twice as high as that of other races [11].

Studies also highlight a low rate of PCa screenings among African men [12,13,14]. This has been attributed to obstacles surrounding insufficient access to cancer-related healthcare, such as diagnosis and treatment; mistrust of healthcare systems; a reluctance to seek medical care; unfavorable attitudes toward research; and a general lack of knowledge regarding risk factors [12, 15,16,17]. Similarly, Rogers et al. [16] and Lillard et al. [18] claimed that there is a low rate of participation in cancer research as participants among black men, which has resulted in a scarcity of evidence regarding genetic variations between black and white men. Other factors that increase the likelihood of prostate cancer include age, hormones, genetics, diet, low socioeconomic status, and exposure to human papilloma viruses (HPVS) and poliyomaviruses [8, 19]. In Namibia, cancer screening services such as PCa screening are widely available for little or no cost at public health facilities in Namibia [20]. Namibia has one of the highest rates of deaths due to PCa in sub-Saharan Africa, with 1,022 deaths per 100,000 men [10], but PCa screening has historically been a low public health priority [20]. Although prostate cancer constitutes 44.8 cases per 100,000 men among all cancer types in Namibia [21], PCa screening uptake is just 16% among eligible men [20, 22]. Moreover, Namibia remains one of the country with high disparities in accessing prostate cancer screening, and high years of life lost in sub-Saharan Africa due to PCa [23].

The most commonly utilized serological techniques for detecting prostate cancer involves the measurement of Prostate-Specific Antigen (PSA) and a digital rectal examination [23]. PSA is considered to be practical and straightforward, while still maintaining a high level of sensitivity. In fact, it boasts a specificity rate of 97% and a sensitivity rate of 67%, making it an effective tool for identifying the presence of the disease. Early detection through screening can help reduce the probability of advanced disease, decrease the likelihood of death due to prostate cancer, and improve life expectancy [20].

Prostate cancer (PCa) screening is recommended for men aged 40 and above [24,25,26]. However, a PCa diagnosis can have significant psychological effects, such as mood disturbances and depression, which may be linked to decreased testosterone levels resulting from PCa treatment [15]. Nevertheless, multiple studies [8, 27, 28] have indicated that black men exhibit limited awareness regarding PCa, resulting in a significantly low rate of participation in screening initiatives. Moreover, research indicates that most men are socialized to exhibit traits such as dominance, strength, and physical aggression, while avoiding any expression of emotion or vulnerability [9]. As they transition from childhood to adulthood, men are conditioned to demonstrate behaviors that conform to gender role expectations of mistrust rooted in masculine ideologies [29]. Evidence suggests that, due to societal notions of masculinity, men typically have a reluctance to appear vulnerable, which consequently hinders their willingness to undergo screening tests for prostate cancer (PCa) [15, 21]. Furthermore, a study examining the barriers to prostate cancer screening among men in Sub-Saharan Africa posited that some individuals harbour homophobic attitudes towards the PCa procedure, primarily arising from concerns regarding potential uncontrolled sexual arousal during the examination [15].

The national guidelines on PCa screening in Namibia lean toward those of the US Preventive Services Task Force (USPSTF). The 2008 USPSTF recommendations were against PSA screening for prostate cancer in men aged 50 years and older, over concerns regarding over-detection and treatment morbidity contributing to a decline in PSA screening rates [30]. This reduction led to an increase in the incidence of advanced-stage prostate cancer, however [30, 31]. Yet even after the reversal of the decision-making recommendations regarding potential benefits and harms in 2018, which subsequently supported PCa screening for men aged 50 and above [31], PCa screening in Namibia among the eligible population remains low.

This study describes the facilitators of, and barriers to, PCa screening uptake among men between the ages of 50 and 70 at the oncology and urology departments of a local referral hospital in Oshana region, Namibia. Understanding the factors that influence PCa screening uptake in this age group is crucial for optimizing screening programs and improving early detection rates, ultimately impacting PCa-related morbidity and mortality. This knowledge can inform targeted interventions to address barriers and leverage facilitators, promoting more informed decision-making regarding PCa screening.

Methods

Design and setting

The study employed a qualitative, descriptive, phenomenological design to describe the facilitators of, and barriers, to prostate cancer screening among men between the ages of 50 and 70 years at an oncology and urology departments of an intermediate hospital in Oshana region in Namibia. In line with prior studies [32,33,34], a descriptive phenomenological approach was used to gain a deeper understanding of the participants’ lived experiences and the meaning of these experiences regarding the barriers to, and facilitators of, PCa screening among older men in Namibia. The philosophical stance of this study was informed by methodological principles that prioritize openness, excluding the researcher’s preconceived assumptions, and fostering a reflective approach [32]. The intermediate hospital is situated in the Oshana region and serves as a referral hospital for three other regions, namely the Omusati, Ohangwena, and Oshikoto regions, with a combined population of close to one million people [35]. Community-based PCa screening in the region is limited to yearly campaigns. Resource limitations restrict other regional clinics and health centers to skeletal staff (nurses only), necessitating that patients requiring PCa screening tests, including PSA testing, be referred to this specialized hospital. It is estimated that the hospital conducts close to 500 PSA tests and rectal examinations and diagnose close to 50 patients every month with prostate cancer.

Population and recruitment

The researcher interviewed 15 men aged between 50 and 70 during their visit to the oncology and urology departments of the local referral hospital in the Oshana region. A non-probability convenience sampling technique was used to select elderly men who were conveniently available to the researcher [36] in two of the departments of the selected hospital. The inclusion criteria were being: (1) men aged 50 years or above; (2) were at the hospital for PCa screening; (3) did not have total hearing impairment; and (4) were mentally stable. In this study the exclusion of deaf participants was based on the assumption that an inability to establish effective communication would not only cause emotional distress but also negatively impact data quality, thereby compromising the validity of the results. We excluded eligible participants who were mental unstable or critical sick patients.

Data collection

As is common in phenomenological studies, data were collected through in-depth individual interviews in line with the research questions. This qualitative descriptive phenomenological study used a self-developed, semi-structured interview guide (See supplementary file) in line with existing literature [32, 37] and study objectives to investigate the perceptions of the facilitators of, and barriers to, PCa screening among older men. These studies [32, 37], share a common ontological and epistemological foundation regarding the understanding of lived experiences and utilized comparable data collection techniques. This study did not incorporate a theoretical framework consistent with Husserl’s perspective, which asserts that phenomenological inquiry should be free from assumptions or philosophical theories, as it aims to accurately describe an individual’s direct lived experience [33]. Data were collected between September and October 2022. One of the researchers (FMB) approached potential participants at the hospital and explained the purpose and the significance of the study, before seeking their voluntary participation and consent to take part in the research. Face-to-face interviews were conducted with 15 participants to draw upon their perceptions, feelings, and beliefs about PCa screening. Probing questions included further details regarding the factors that motivated or demotivated them to pursue prostate cancer screening to elicit more information regarding prostate cancer screening. The interviews were audio recorded while field notes captured the participants’ bodily expressions. The interviews were conducted in secure rooms and took between 45 and 50 min each.

Data analysis

The researchers listened to the interview recordings several times before the primary researcher (FMB) transcribed them word for word. Following verification of transcript accuracy against audio recordings by the first author (NT), verbatim transcripts were subjected to manual inductive analysis. Microsoft Word, specifically its highlighting functionality, facilitated this process by enabling the coding of textual data and the subsequent organization and tracking of emergent themes and subthemes, consistent with Colaizzi’s seven-step methodology: (1) the descriptions provided by all participants were read; (2) key statements related to the obstacles and enablers affecting the uptake of prostate cancer screening were identified;

(3) interpretations for each key statement were derived; (4) meanings were organized into cluster themes; (5) results were synthesized into a comprehensive narrative; (6) comprehensive statements regarding findings were developed; and (7) the identified themes were validated with the study participants [38, 39].

To extract significant statements on barriers and facilitators, the principal investigator (FMB) used structural coding to assign different colors to label passages with statements that were related to the research questions, such as age and family history as facilitators of PCa screening. He then came together with the first author (NT) to agree and make a joint decision on statements supporting the study objectives. Thematic and code saturation was attained with 15 participants, as the emergence of repetitive themes and codes indicated that no new information was forthcoming.

To synthesize the exhaustive description of the results, the cluster themes were further organized into groups related to the participants’ experiences regarding their uptake of PCa screening. During this stage, the transcripts were re-read for accuracy and authenticity of themes. Redundancy or unnecessary information were removed by the first author (NT). As per Husserl [40], the data analysis extended beyond mere sensory perception to encompass the participants’ experiences of thoughts, emotions, imagination, and memories. Prior research conducted by Owoo et al. [37], which investigated the challenges encountered by caregivers of prostate cancer patients in Cape Coast, Ghana, served as a reference point for data analysis. The identified themes were then validated with the study participants, although no discrepancies were observed. The participants’ facial expressions were added to the quotations by comparing the field notes with the audio recordings.

Ethical considerations

The study was carried out with the approval of the Ethical Committee of the School of Nursing and Public Health at the University of Namibia (SoNEC 112/2022) and the Ministry of Health and Social Services (Ref: 22/3/1/2). All the participants provided written informed consent before joining the study. The participants were also notified that they had the option to withdraw from the study at any point. The study adhered to the principles of the revised Declaration of Helsinki guidelines for medical research that involves human subjects.

Trustworthiness

The trustworthiness of this study was achieved based on the following four criteria: credibility, transferability, dependability, and confirmability [41]. Credibility was achieved by obtaining participant approval, describing the phenomenon under investigation in detail though word by word checking, analyzing the data, and having experienced researchers on the team who had experience in qualitative research and analysis. An independent coder arrived at the same conclusion as the authors on the developed themes, thus the findings could be compared with the findings of previous research. Data were also shown to the participants to confirm their accuracy.

In order to achieve transcendental subjectivity, bracketing was ensured by excluding the researchers’ pre-existing knowledge and assumptions pertaining to the phenomenon under investigation and by taking note of their own biases and assumptions [38]. Mental preparation, defining the scope of the literature review, planning a data collection method that was immune to bias, and conducting an analysis that enhanced trustworthiness were essential components of the research process [42]. To ensure mental preparation, the researchers articulated their philosophical standpoint of openness, critically examined their own preconceived notions, and adopted a reflective approach [32]. The study included a preliminary review of the literature to help the researchers comprehend the research question, with a comprehensive literature review reserved for the post-analysis phase. In line with the tradition of phenomenological studies, data collection involved semi-structured interviews. The study also followed Colaizzi’s 7-step method for data analysis, which bolstered the overall trustworthiness, as the researchers returned to the participants at the seventh step.

To ensure transferability, the research sample, environment, and study research process were presented clearly and the participants’ statements were quoted verbatim. Dependability was achieved by sending all the data collection tools, raw data, encodings made during the analysis phase, and the drawn inferences to an independent coder who was not involved in the research. Confirmability was ensured by using more than one data collection method, considering each researcher’s reflective comments, and having each researcher code the data individually. Furthermore, the process of member checking was employed to obtain the reflective viewpoints of the participants on the study findings, rather than solely depending on the researchers’ interpretations.

Results

General characteristics of study participants

The study recruited 15 men aged 50 to 70 who were willing to participate. More than half (60%; n = 9) of the participants were single, while 40% (n = 6) were married. The participants’ educational level included 73% (n = 11) with basic junior and secondary certificates, and 27% (n = 4) with tertiary qualifications. Almost half (47%; n = 7) of the participants were employed, while 53% (n = 8) were unemployed. Most of the participants (67%; n = 10) had to travel more than 10 km to the hospital, while 33% (n = 5) had to travel a distance of less than 10 km (see Table 1).

Table 1 Participants demographic data

Presentation of themes

Table 2 shows the two interrelated themes that were generated from the study: (1) Value of early detection, which describes the participants’ perceptions regarding what facilitated their uptake of prostate cancer screening; and (2) Potential threats to PCa screening, which describes the participants’ perceptions regarding the barriers to cancer screening.

Table 2 Themes and subthemes

Theme 1: perceived value of early detection

This theme emerged when the participants were asked to describe their experiences with regard to prostate cancer screening services. The in-depth interviews led to three subthemes being developed, i.e., advanced age; personal or family history of PCa; and family and community support, which were described as facilitators of PCa screening.

Subtheme 1: advanced age

Participants revealed that advanced age was a risk factor for PCa. Most participants felt that their perception of PCa being more likely as they got older motivated them to seek screening services as early as possible as a preventative measure.

I was informed prostate cancer is very common among older men. As you get older your body also start to weaken, making it vulnerable to many ailments. So I came to this clinic, so I make sure I get assisted fast if the test come positive for cancer.” (P3, pensioner).

I only come to the hospital for prostate cancer test because of my old age. I think that is the reason why you don’t really see so many younger people here.” (P1, employed).

Subtheme 2: personal or family history of PCa

Some of the participants felt that having a family member that had suffered from PCa was a risk, commenting that men with a history of PCa in their families often seek early screening.

I fear prostate cancer these days. We lost our brother [cousin] to this disease just a year ago. At the time of diagnosis, they said it was too late to assist him as the cancer was already advanced [metastasized] and had spread to other parts of the body. This incident is the one that made me to start looking for prostate cancer screening.” (P5, employed).

Subtheme 3: family and community support

Participants highlighted how having support at home and in the community can encourage more men to seek PCa screening services. They expressed their desire to be surrounded by people who can provide them with support if they turned out to have PCa.

“I had no intention to seek cancer screening test, but my wife and older son encouraged me to go for this test. I feel I drew inspiration from my family to come for this test. I hope for their continuous support if I test positive for prostate cancer.” (P15, Unemployed).

“I believe that psychosocial support plays a crucial role in facilitating the acceptance of a cancer diagnosis, aiding in treatment, and assisting individuals in overcoming the challenges associated with this disease. Apart from having family support, I feel motivated because we have a small supporting community group in our constituency.” (P11, employed).

Theme 2: potential threats to PCa screening

The participants identified various barriers to PCa screening, which fell into three subthemes: limited understanding of PCa; lack of local access to screening; and cultural beliefs and stigmatization.

Subtheme 1: limited Understanding of the disease

Participants expressed that a lack of ​knowledge hindered their willingness to participate in screening. Additionally, misconceptions surrounding the test​s, particularly those regarding their implications for men’s sexual lives, further discouraged individuals from​ undergoing screening.

“[stuttering] It is a test of sexual function. Once you are diagnosed with prostate cancer, you will never be able to have sex with your sexual partner. I heard people lose their sexual function after treatment, especially after operation.” (P7, pensioner).

One participant proposed that PCa is as a result of men having sex with each other, thus the test is not meant for straight men.

“Prostate cancer screening is mostly needed by the gay men as this cancer is a result of men having sex with each other. I don’t think straight men are the really ones affected by this.” (P10, unemployed).

Two participant felt that PCa screening is particularly for those with sexual addictions or who have a sexual dysfunction. These participants argued that PCa screening should be necessitated by illness rather than being done in the absence of any complaints or while in good health.

“You can only come for this screening if you are unhealthy, like maybe you have sexual dysfunction. Like those who have more than five or more sexual encounters every day and sometimes with different women.” (P14, employed).

“[Looking down] One of the reasons preventing most adult men hesitate going for PCa screening as the community [sees] it as a sign of sexual dysfunction. (P12, unemployed)

Subtheme 2: lack of local access to screening

Participants expressed concerns about the long distances to hospitals as a barrier to accessing PCa screening services locally. Ten participants also shared their concerns about the costs involved in travelling these distances.

“Getting to the hospital is often difficult as we do not have car leaving the village to town daily, as PCa services are only provided there. It’s even worse to us old people as often drivers overload passages in their cars as a way of making more money. Travelling in overloaded vans for a long distance like 30km is a challenge to me, so I keep postponing going to the hospital for my health needs.” (P6, pensioner).

Six of the participants felt that the lack of PCa screening services at nearby clinics is a major reason why people travel long distances to seek for PCa screening services.

“The absence of prostate cancer screening at the nearby clinic make many people to miss important health services, including prostate cancer screening.” (P9, pensioner).

Subtheme 3: cultural beliefs and stigmatization

A plethora of reasons given for the lack of uptake of prostate cancer screening services were related to cultural beliefs and stigmatization against men seeking screening services or living with PCa. Five of the participants highlighted that there is a belief that the majority of men seeking PCa screening are gay, as they can more easily deal with the insertion of fingers into their anus.

“[Raised eyebrows] It is fresh in my mind how people think my friend turned into gay, just because he said he agreed to the doctor to insert his gloved fingers in his anus during rectal examination. With this stigma surrounding the screening process of prostate cancer in this community, one is hesitant to show up for the test and even to reveal that you are diagnosed with PCa out of fear to be discriminated against.” (P9, pensioner).

“In my culture as a straight man you cannot allow another person to touch your buttocks. Only gay can do that. While I personally understand why a doctor insert the fingers into the patients’ anus, our cultural beliefs are against it. Those with strong beliefs in culture can view this differently and may take time before most men become comfortable with this test.” (P2, unemployed).

Discussion

This study identified various facilitators of, and barriers to, PCa screening, which should be considered when promoting this health care to older men in comparable contexts. The growing prevalence of prostate cancer-related deaths among elderly men highlights the need to understand these facilitators and barriers. The value of early detection was identified as a facilitator of PCa screening in this study, which has deep roots in self-motivation and the value that an individual patient places on screening [43]. Previous literature found that early disease screening can be influenced by age, an individual’s history with PCa, and family and support networks [5, 44]. Most participants in this study felt that their advanced age was a risk factor in developing PCa, hence their decision to go for screening. Although the incidences of prostate cancer have risen across various ages [45], extant research warns that prostate cancer predominantly affects older men [8, 46,47,48]. In light of their heightened susceptibility to prostate cancer (PCa) and other related conditions that come with advancing age, it is crucial to enhance the effectiveness of awareness campaigns aimed at reaching all men who are at risk [49, 50].

A family history of PCa was found to be a motivator for seeking screening services, as participants reported this as their reason for visiting the health facility. Although the exact cause of prostate cancer is not yet fully understood, several modifiable and non-modifiable factors have been identified that could potentially contribute to its development. While these factors include age, ethnicity, and hormones, family history is one of the major non-modifiable risk factors necessitating screening for early detection while modifiable factors such as alcohol consumption, smoking, and certain medications may demand lifestyle modifications [15, 51]. Given their potential increased susceptibility to prostate cancer (PCa), black patients should be prioritized for cancer screening [52]. Therefore, integrating non-modifiable risk factors, such as emphasizing the role of family history in PCa awareness campaigns, could potentially increase screening uptake. Further studies are needed to explore the most effective strategies for communicating risk and promoting screening among Black men, including culturally tailored approaches that address potential barriers to access and address concerns about the screening process. The analysis suggests that having family support and support groups could encourage more men to seek PCa screening services. Congruent with existing literature [53], participants expressed their desire to be surrounded by people who can provide them with support if they test positive for PCa. Current evidence indicates that social support is the foundation upon which patients adapt to new circumstances and enhance their quality of life [54]. Support groups also offer a valuable platform for men to engage in open discussions regarding their health concerns with other men. Such interactions can significantly impact their decision-making process, particularly in relation to screening, as they have the opportunity to witness firsthand the experiences of other men who are already coping with prostate cancer [55].

While the study identified facilitators to PCa screening, there were more barriers than facilitators. One of these barriers is a limited understanding of prostate cancer. Misconceptions surrounding the tests have discouraged individuals from undergoing screenings, particularly due to the perceived implications for men’s sexual lives. This finding supports those of the literature review, which suggest that a lack of knowledge is a barrier to prostate cancer screening [15]. Furthermore, some participants mistakenly believed that prostate cancer is solely a result of homosexual encounters, leading to the misconception that the test is not meant for heterosexual men. This lack of understanding is likely to discourage men from participating in screening due to the stigma associated with the disease within the community [26]. For this reason, it is imperative to cultivate a cultural construct of masculinity and provide access to reliable information pertaining to PCa, in order to foster a heightened sense of perceived threat or vulnerability [56].

Some noteworthy research suggests that while PCa screening has been shown to decrease mortality rates associated with prostate cancer, there is an ongoing debate surrounding the decision to undergo screening due to the significant issue of over-diagnosis that arises from the utilization of PSA-based screening methods [31, 57,58,59]. Over screening has the potential to cause psychological distress, which may result in depression, urinary incontinence, and erectile dysfunction [58]. This dilemma highlights the complexity of balancing the potential benefits of early detection with the risks of unnecessary and potentially harmful treatments resulting from false-positive test results.

Another major barrier to PCa screening is a lack of local access. Participants expressed concerns over the inconvenience due to traveling long distances. This finding reinforces the global perspective on access to prostate cancer screening in Africa [60, 61], particularly for men residing in rural areas who encounter significant disadvantages and vulnerabilities due to the high costs and limited availability of specialized cancer care services, which are predominantly concentrated in urban regions [56]. As discussed, the disparity in screening rates between rural and urban areas can be attributed to the limited accessibility of healthcare services in rural areas, which continues to pose a persistent global challenge in both low- and high-income countries [23, 26]. Furthermore, stigma has a negative impact on prostate cancer patients, manifesting as anxiety and depression, uncertainty about their illness, and being linked to erectile dysfunction [62, 63].

It is thus important to address both individual barriers, such as limited understanding, and external factors, such as cultural stigmatization, to effectively to improve access to, and use of, PCa screening.

Strength and limitations

The study’s strengths include the consideration of a wide range of socio-economic and demographic characteristics, as well as including both rural and urban residents. The findings are especially valuable for researchers, clinicians, and policymakers who are working on developing interventions and policies to increase prostate cancer screening among older men.

The study’s limitations include that although it was conducted in a town comprising approximately seven sub-tribes, the barriers and facilitators specific to each sub-tribe were not analyzed. This lack of analysis may have resulted in an inadequate understanding of how men from different sub-tribes perceive PCa screening.

Conclusion

The study revealed several modifiable obstacles to prostate cancer screening, including fear of stigmatization, insufficient knowledge, and limited access to screening. Conversely, factors such as older age, a family history of PCa, and social support can enhance the likelihood of screening. These results underscore the importance of integrating non-modifiable risk factors, namely family history and age, into existing PCa educational campaigns to increase screening uptake. In light of these findings, the study recommends the development of gender-specific campaigns that address issues related to masculinity, knowledge deficits, and cultural beliefs and stigmatization to create an effective screening strategy for the targeted male demographic.

Data availability

Data is available from the corresponding author upon reasonable request.

Abbreviations

PCa:

Prostate cancer

PSA:

Prostate-Specific Antigen

SoNEC:

School of Nursing Ethics Committee

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424. https://doiorg.publicaciones.saludcastillayleon.es/10.3322/caac.21492.

    Article  Google Scholar 

  2. Abu-Odah H, Molassiotis A, Liu J. Challenges on the provision of palliative care for patients with cancer in low-and middle-income countries: a systematic review of reviews. BMC Palliat Care. 2020;19:1–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12904-020-00558-5.

    Article  Google Scholar 

  3. Nascimento-Gonçalves E, Faustino-Rocha AI, Seixas F, Ginja M, Colaço B, Ferreira R, Fardilha M, Oliveira PA. Modelling human prostate cancer: rat models. Life Sci. 2018;203:210–24. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.lfs.2018.04.014.

    Article  CAS  PubMed  Google Scholar 

  4. Dickey SL, Cormier E, Whyte IVJ, Ralston PA. Intrapersonal and community factors associated with prostate cancer screening among African-American males in the US. Nursing: Res Reviews. 2016;28:33–42. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/NRR.S96399.

    Article  Google Scholar 

  5. Iheanacho CO, Odili VU, Enakirerhi GE, Isiwele EM, Essiet A, Pattern. Clinical characteristics, and impact of family history on prostate-Specific antigen in prostate cancer: A multicenter study. Am J Men’s Health. 2024;18(4):15579883241264949. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/1557988324126.

    Article  Google Scholar 

  6. Bello JO, Buhari T, Mohammed TO, Olanipekun HB, Egbuniwe AM, Fasiku OK, Wasiu R. Determinants of prostate specific antigen screening test uptake in an urban community in North-Central Nigeria. African Health Sciences. 2019; 18;19(1):1665-70.

  7. Marais B, Klopper G, John J. Prostate cancer perspective: Africa versus the world. South Afr Med J. 2024;1(4):21–5.

    Google Scholar 

  8. Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, Stattin P, Van Poppel H, La Vecchia C. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;1(6):877–92. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.euo.2021.09.006.

    Article  Google Scholar 

  9. Esiaka D, Nwakasi C, Brodie K, Philip A, Ogba K. Dying to be men: masculinity and early Cancer detection among Nigerian men. Community Health Equity Res Policy. 2022;42(4):351–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0272684X211004938.

    Article  Google Scholar 

  10. Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S, Nicholson B, Rebbeck TR, Lu-Yao G. Current and projected number of years of life lost due to prostate cancer: A global study. Prostate. 2022;82(11):1088–97. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/pros.24360.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63. https://doiorg.publicaciones.saludcastillayleon.es/10.14740/wjon1191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EE, Omoregbe N, Ayo CK. An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis. PLoS ONE. 2016;13(4):e0153496. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0153496.

    Article  CAS  Google Scholar 

  13. Enemugwem RA, Eze BA, Ejike U, Asuquo EO, Tobin A. Prostate cancer screening: assessment of knowledge and willingness to screen among men in Obio Akpor LGA, rivers State, Nigeria. Afr J Urol. 2019;25:1–4. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12301-019-0010-5.

    Article  Google Scholar 

  14. Chowdhury-Paulino IM, Ericsson C, Vince R Jr, Spratt DE, George DJ, Mucci LA. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate cancer and prostatic diseases. 2022;25(3):397–402. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41391-021-00451-z

  15. Baratedi WM, Tshiamo WB, Mogobe KD, McFarland DM. Barriers to prostate cancer screening by men in Sub-Saharan Africa: an integrated review. J Nurs Scholarsh. 2020;52(1):85–94. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/jnu.12529.

    Article  PubMed  Google Scholar 

  16. Rogers CR, Rovito MJ, Hussein M, Obidike OJ, Pratt R, Alexander M, Berge JM, Dall’Era M, Nix JW, Warlick C. Attitudes toward genomic testing and prostate cancer research among black men. Am J Prev Med. 2018;1(5):S103–11. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.amepre.2018.05.028.

    Article  Google Scholar 

  17. Hamdi Y, Abdeljaoued-Tej I, Zatchi AA, Abdelhak S, Boubaker S, Brown JS, Benkahla A. Cancer in Africa: the untold story. Front Oncol. 2021;15:11:650117. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fonc.2021.650117.

    Article  CAS  Google Scholar 

  18. Lillard JW Jr, Moses KA, Mahal BA, George DJ. Racial disparities in B lack men with prostate cancer: A literature review. Cancer. 2022;1(21):3787–95. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cncr.34433.

    Article  Google Scholar 

  19. Mutua K, Pertet AM, Otieno C. Cultural factors associated with the intent to be screened for prostate cancer among adult men in a rural Kenyan community. BMC Public Health. 2017;17:1–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12889-017-4897-0.

    Article  Google Scholar 

  20. Kangmennaang J, Mkandawire P, Luginaah I. What prevents men aged 40–64 years from prostate cancer screening in Namibia? J Cancer Epidemiol. 2016;2016(1):7962502. https://doiorg.publicaciones.saludcastillayleon.es/10.1155/2016/7962502.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Marima R, Mbeje M, Hull R, Demetriou D, Mtshali N, Dlamini Z. Prostate cancer disparities and management in Southern Africa: insights into practices, norms and values. Cancer Manage Res. 2022;31:3567–79. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/CMAR.S382903.

    Article  Google Scholar 

  22. Nakwafila O. Knowledge and attitudes towards prostate cancer screening amongst men in Oshana region, Namibia (Doctoral dissertation, University of Namibia).

  23. Abila DB, Wasukira SB, Ainembabazi P, Kisuza RK, Nakiyingi EK, Mustafa A, Kangoma G, Adebisi YA, Lucero-Prisno DE III, Wabinga H, Niyonzima N. Socioeconomic inequalities in prostate cancer screening in low-and middle-income countries: an analysis of the demographic and health surveys between 2010 and 2019. J Cancer Policy. 2022;1:34:100360. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jcpo.2022.100360.

    Article  Google Scholar 

  24. Catalona WJ. Prostate cancer screening. Medical Clinics. 2018; 1;102(2):199–214. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.mcna.2017.11.001

  25. Shoag JE, Nyame YA, Gulati R, Etzioni R, Hu JC. Reconsidering the trade-offs of prostate cancer screening. N Engl J Med. 2020;6(25):2465. https://doiorg.publicaciones.saludcastillayleon.es/10.1056/NEJMsb2000250.

    Article  Google Scholar 

  26. Mbugua RG, Oluchina S, Karanja S. Prostate cancer awareness and screening among men in a rural community in Kenya: A cross-sectional study. Afr J Urol. 2021;27:1–0. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12301-020-00108-8.

    Article  Google Scholar 

  27. Malika N, Roberts L, Alemi Q, Casiano CA, Montgomery S. Ethnic differences among black men in prostate cancer knowledge and screening: a mixed-methods study. J Racial Ethnic Health Disparities. 2021;30:1–2. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s40615-021-01027-2.

    Article  Google Scholar 

  28. Maphayi MR, Cassim N, Bello B, George JA. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa. Pan Afr Med J. 2020;28(1). https://doiorg.publicaciones.saludcastillayleon.es/10.11604/pamj.2020.35.61.21331.

  29. Brooks E, Islam JY, Perdue DG, Petersen E, Camacho-Rivera M, Kennedy C, Rogers CR. The black Panther, masculinity barriers to medical care, and colorectal cancer screening intention among unscreened American Indian/Alaska native, black, and white men. Front Public Health. 2022;6:10:814596. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpubh.2022.814596.

    Article  Google Scholar 

  30. Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. European urology. 2020; 1;77(1):38–52. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.eururo.2019.08.005

  31. Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and Temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;16(10):811044.

    Article  Google Scholar 

  32. Sundler AJ, Lindberg E, Nilsson C, Palmér L. Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019;6(3):733–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/nop2.275.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Shorey S, Ng ED. Examining characteristics of descriptive phenomenological nursing studies: A scoping review. J Adv Nurs. 2022;78(7):1968–79. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/jan.15244.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wu G, Lin Y, Huang X, Zheng J, Chang M. A qualitative study of ICU nurses assisting in Wuhan who suffered from workplace violence during the COVID-19 outbreak. Nurs Open. 2023;10(11):7314–22. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/nop2.1984.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Namibia Statistics Agency. Population and Housing Census Main Report. Namibia Statistics Agency. 2011. https://cms.my.na/assets/documents/p19dmn58guram30ttun89rdrp1.pdf. Accessed 10 August 2023.

  36. Berndt AE. Sampling methods. J Hum Lactation. 2020;36(2):224–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0890334420906850.

    Article  Google Scholar 

  37. Owoo B, Ninnoni JP, Ampofo EA, Seidu AA. Challenges encountered by family caregivers of prostate cancer patients in cape Coast, Ghana: a descriptive phenomenological study. BMC Palliat Care. 2022;14(1):108. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12904-022-00993-6.

    Article  Google Scholar 

  38. Allman M, Nava A, Asim N, Brashear B, Walton QL, McFarlane J, Sharp C. Using the Colaizzi method to explore intimate partner violence caseworkers’ subjective experience: pathways to intimate partner violence work and what keeps them going. Violence against Women. 2024;30(1):174–88.

    Article  PubMed  Google Scholar 

  39. Colaizzi PF. Psychological research as the phenomenologist views it. In: Valle RS, King M, editors. Existential-phenomenological alternatives for psychology. Oxford University Press; 1978. pp. 48–71.

  40. Neubauer BE, Witkop CT, Varpio L. How phenomenology can help Us learn from the experiences of others. Perspect Med Educ. 2019;8:90–7.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lincoln YS. Naturalistic inquiry. sage; 1985.

  42. Ataro G. Methods, methodological challenges and lesson learned from phenomenological study about OSCE experience: overview of paradigm-driven qualitative approach in medical education. Annals Med Surg. 2020;1:49:19–23. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.amsu.2019.11.013.

    Article  Google Scholar 

  43. Estevan-Vilar M, Parker LA, Caballero-Romeu JP, Ronda E, Hernández-Aguado I, Lumbreras B. Barriers and facilitators of shared decision-making in prostate cancer screening in primary care: A systematic review. Prev Med Rep. 2023;12:102539. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.pmedr.2023.102539.

    Article  Google Scholar 

  44. Fox L, Wiseman T, Cahill D, Beyer K, Peat N, Rammant E, Van Hemelrijck M. Barriers and facilitators to physical activity in men with prostate cancer: a qualitative and quantitative systematic review. Psycho-oncology. 2019;28(12):2270–85. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/pon.5240.

    Article  PubMed  Google Scholar 

  45. Bleyer A, Spreafico F, Barr R. Prostate cancer in young men: An emerging young adult and older adolescent challenge. Cancer. 2020; 1;126(1):46–57. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cncr.32498

  46. Liu X, Yu C, Bi Y, Zhang ZJ. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health. 2019;1:172:70–80. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.puhe.2019.04.016.

    Article  Google Scholar 

  47. Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N, Oudard S, Payne H, Prentice M, Puts M, Aapro M. Updated recommendations of the international society of geriatric oncology on prostate cancer management in older patients. Eur J Cancer. 2019;1:116:116–36. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ejca.2019.04.031.

    Article  Google Scholar 

  48. Desai MM, Cacciamani GE, Gill K, Zhang J, Liu L, Abreu A, Gill IS. Trends in incidence of metastatic prostate cancer in the US. JAMA Netw Open. 2022;1(3):e222246. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cncr.32630.

    Article  Google Scholar 

  49. Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE. Success of prostate and testicular cancer awareness campaigns compared to breast cancer awareness month according to internet search volumes: a Google trends analysis. Urology. 2020;1:139:64–70. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.urology.2019.11.062.

    Article  Google Scholar 

  50. Gift S, Nancy K, Victor M. Assessment of knowledge, practice and attitude towards prostate cancer screening among male patients aged 40 years and above at Kitwe teaching hospital, Zambia. Afr J Urol. 2020;26:1–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12301-020-00067-0.

    Article  Google Scholar 

  51. Ng KL. The etiology of prostate cancer. Exon Publications. 2021;27:17–27. https://doiorg.publicaciones.saludcastillayleon.es/10.36255/exonpublications.prostatecancer.etiology.2021.

    Article  Google Scholar 

  52. Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN. Prevalence of suspected hereditary cancer syndromes and germline mutations among a diverse cohort of probands reporting a family history of prostate cancer: toward informing cascade testing for men. Eur Urol Oncol. 2020;1(3):291–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.euo.2019.06.010.

    Article  Google Scholar 

  53. Cobran EK, Hall JN, Aiken WD. African-American and Caribbean-born Men’s perceptions of prostate cancer fear and facilitators for screening behavior: A pilot study. J Cancer Educ. 2018;33:640–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s13187-017-1167-x.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Ruiz-Rodríguez I, Hombrados-Mendieta I, Melguizo-Garín A, Martos-Méndez MJ. The importance of social support, optimism and resilience on the quality of life of cancer patients. Front Psychol. 2022;9:13:833176. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpsyg.2022.833176.

    Article  Google Scholar 

  55. Shemesh B, Opie J, Tsiamis E, Ayton D, Satasivam P, Wilton P, Gough K, Lewis K, O’Brien C, Shub M, Pomery A. Codesigning a patient support portal with health professionals and men with prostate cancer: an action research study. Health Expect. 2022;25(4):1319–31. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/hex.13444.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Adedeji IA, Lawal SA, Aluko-Arowolo S. Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening. Cancer Causes Control. 2021;32(8):895–901. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10552-021-01444-y.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Van Poppel H, Albreht T, Basu P, Hogenhout R, Collen S, Roobol M. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Reviews Urol. 2022;19(9):562–72. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41585-022-00638-6.

    Article  Google Scholar 

  58. Walter SD, Hu J, Talala K, Tammela T, Taari K, Auvinen A. Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European randomized study of screening for prostate Cancer. Cancer Causes Control. 2021;32:1299–313. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10552-021-01480-8.

    Article  CAS  PubMed  Google Scholar 

  59. Welch HG, Bergmark R. Cancer screening, incidental detection, and overdiagnosis. Clin Chem. 2024;70(1):179–89. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/clinchem/hvad127.

    Article  CAS  PubMed  Google Scholar 

  60. Jalloh M, Cassell A, Niang L, Rebbeck T. Global viewpoints: updates on prostate cancer in Sub-Saharan Africa. BJU Int. 2024;133(1):6–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/bju.16178.

    Article  PubMed  Google Scholar 

  61. Cassell A, Yunusa B, Jalloh M, Mbodji MM, Diallo A, Ndoye M, Kouka SC, Labou I, Niang L, Gueye SM. A review of localized prostate cancer: an African perspective. World J Oncol. 2019;10(4–5):162. https://doiorg.publicaciones.saludcastillayleon.es/10.14740/wjon1221.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Vapiwala N, Miller D, Laventure B, Woodhouse K, Kelly S, Avelis J, Baffic C, Goldston R, Glanz K. Stigma, beliefs and perceptions regarding prostate cancer among black and Latino men and women. BMC Public Health. 2021;21:1–1. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12889-021-10793-x.

    Article  Google Scholar 

  63. Pan S, Wang L, Zheng L, Luo J, Mao J, Qiao W, Zhu B, Wang W. Effects of stigma, anxiety and depression, and uncertainty in illness on quality of life in patients with prostate cancer: a cross-sectional analysis. BMC Psychol. 2023;25(1):129. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40359-023-01159-6.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank the University of Namibia and Ministry of health and Social Services for ethical approval. We also want to acknowledge all the participants for their time to participate in this study.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

NT: Conceptualization, methodology, supervision, data curation, formal analysis, writing-original draft, writing-review and editing. FMB: Conceptualization, methodology, data curation, formal analysis. All researchers contributed to the manuscript’s drafting, approved the final version and to have agreed both to be personally accountable for the author’s own contributions and can ensure accuracy of information related to this manuscript.

Corresponding author

Correspondence to Nestor Tomas.

Ethics declarations

Ethics approval and consent to participate

The study was carried out with the approval of the Ethical Committee of the School of Nursing and Public Health at the University of Namibia (SoNEC 112/2022) and the Ministry of Health and Social Services (Ref: 22/3/1/2). All the participants provided written informed consent before joining the study. The participants were also notified that they had the option to withdraw from the study at any point. The study adhered to the principles of the revised Declaration of Helsinki guidelines for medical research that involves human subjects.

Consent for publication

Written informed consent obtained from the study participants was limited to participation and publication of data only without any identifying images.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tomas, N., Benyamin, F.M. Facilitators of, and barriers to, prostate cancer screening uptake: A descriptive phenomenological study of adult men in Namibia. BMC Urol 25, 131 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12894-025-01721-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12894-025-01721-x

Keywords